<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6929435/results/search/disease/results.xml">
  <result pre="pmcid: 6929435 1066 doi: 10.1186/s10194-019-1066-0 : Review Article Mechanisms of" exact="migraine" post="as a chronic evolutive condition http://orcid.org/0000-0002-7008-6626 Andreou Anna P."/>
  <result pre="indicate if changes were made. Abstract Understanding the mechanisms of" exact="migraine" post="remains challenging as migraine is not a static disorder,"/>
  <result pre="made. Abstract Understanding the mechanisms of migraine remains challenging as" exact="migraine" post="is not a static disorder, and even in its"/>
  <result pre="not a static disorder, and even in its episodic form" exact="migraine" post="remains an &quot;evolutive&quot; chronic condition. Considerable progress has been"/>
  <result pre="and functional and anatomical changes during the progression of a" exact="migraine" post="attack or the transformation of episodic to chronic migraine."/>
  <result pre="of episodic to chronic migraine. Migraine is a life span" exact="neurological disorder" post="that follows an evolutive age-dependent change in its prevalence"/>
  <result pre="in its prevalence and even clinical presentations. As a disorder," exact="migraine" post="involves recurrent intense head pain and associated unpleasant symptoms."/>
  <result pre="and symptoms being involved during each phase. In some patients," exact="migraine" post="can be transformed into a chronic form with daily"/>
  <result pre="play an important role. Introduction Migraine is a recurrent, disabling" exact="neurological disorder," post="involving intense head pain and associated with other unpleasant"/>
  <result pre="life with a significant socioeconomic impact. The toll of chronic" exact="migraine" post="on individual and society is even bigger, as up"/>
  <result pre="3], with nearly half of them in need of a" exact="migraine" post="preventive treatment [ 4]. The World Health Organization ranks"/>
  <result pre="migraine preventive treatment [ 4]. The World Health Organization ranks" exact="migraine" post="as the most prevalent, disabling, long-term neurological condition when"/>
  <result pre="and functional and anatomical changes during the progression of a" exact="migraine" post="attack, or the transformation of episodic to chronic migraine."/>
  <result pre="to chronic migraine. However, understanding disease mechanisms remains challenging as" exact="migraine" post="is not a static disorder, and even in its"/>
  <result pre="not a static disorder, and even in its episodic form" exact="migraine" post="remains an &quot;evolutive&quot; chronic condition. Migraine as a life"/>
  <result pre="affecting children, adults and the elderly. The clinical presentation of" exact="migraine" post="shows an age-dependent change with shorter duration and also"/>
  <result pre="absence of autonomic signs in the elderly. The prevalence of" exact="migraine" post="in children varies, depending on the study and the"/>
  <result pre="differ between girls and boys [ 6, 7]. In adulthood," exact="migraine" post="is more prevalent in women than in men with"/>
  <result pre="A factor that may contribute to the increased prevalence of" exact="migraine" post="in women compared to men in the reproductive years"/>
  <result pre="11, 12], indicating further the influence of hormonal changes on" exact="migraine" post="occurrence. The prevalence of migraine in the elderly is"/>
  <result pre="influence of hormonal changes on migraine occurrence. The prevalence of" exact="migraine" post="in the elderly is about 3.5% with females affected"/>
  <result pre="often than males [ 13, 14]. The clinical manifestation of" exact="migraine" post="is different in childhood from that in adulthood. Pediatric"/>
  <result pre="migraine is different in childhood from that in adulthood. Pediatric" exact="migraine" post="is characterized by shorter attacks with the pain being"/>
  <result pre="be partially responsible for the changes in the prevalence of" exact="migraine" post="in adults and the elderly, another general feature seems"/>
  <result pre="hypothalamic areas to different autonomic control centres during aging in" exact="migraine" post="[ 18]. Readers interested in changes in migraine symptoms"/>
  <result pre="aging in migraine [ 18]. Readers interested in changes in" exact="migraine" post="symptoms during lifespan, as well as, in mechanisms that"/>
  <result pre="Straube and Andreou [ 18]. Genetic and epigenetic component of" exact="migraine" post="Genetic factors may determine susceptibility to migraine, while different"/>
  <result pre="different environmental factors can contribute to the development of a" exact="migraine" post="attack [ 19, 20]. Mainly through genome-wide association studies"/>
  <result pre="frequencies of single nucleotide polymorphisms (SNPs) over the genome in" exact="migraine" post="patients and controls [ 21], it is now understood"/>
  <result pre="will highlight which molecular pathways potentially could be involved in" exact="migraine" post="pathophysiology [ 20]. In the latest GWAS which included"/>
  <result pre="patients and over 300,000 controls, 44 SNPs were associated with" exact="migraine" post="without aura, implicating 38 distinct genomic loci [ 23]."/>
  <result pre="rather unexpected, hypothesis that metal ion homeostasis might contribute to" exact="migraine" post="susceptibility. Only a handful of loci was found to"/>
  <result pre="study highlighted that vascular dysfunction is of great importance in" exact="migraine" post="susceptibility with neuronal dysfunction playing a rather secondary role"/>
  <result pre="link associated SNPs to actual genes and pathways. GWAS in" exact="migraine" post="are yet to offer further knowledge on the functional"/>
  <result pre="genetic studies of hemiplegic migraine, a rare monogenic forms of" exact="migraine" post="[ 24] offered knowledge about specific genes that encode"/>
  <result pre="assays or in mutant murine. In brief, mutations involved in" exact="familial hemiplegic migraine" post="were found in the genes CACNA1A, ATP1A2 and SCN1A,"/>
  <result pre="in mutant murine. In brief, mutations involved in familial hemiplegic" exact="migraine" post="were found in the genes CACNA1A, ATP1A2 and SCN1A,"/>
  <result pre="increased susceptibility to cortical spreading depression, the underlying mechanism of" exact="migraine" post="aura [ 28, 29]. Interestingly, mice carrying the CACNA1A"/>
  <result pre="migraine, to date they failed to explain the pathophysiology of" exact="migraine" post="and evolutive mechanisms. However, it is important to mention"/>
  <result pre="may be able to explain better the mechanisms that transform" exact="migraine" post="into a chronic form in some individuals or achieve"/>
  <result pre="migraine into a chronic form in some individuals or achieve" exact="migraine" post="freedom altogether later in life. Is there a role"/>
  <result pre="in life. Is there a role for epigenetic mechanisms in" exact="migraine" post="susceptibility and chronification? Beyond genetic factors that could be"/>
  <result pre="and chronification? Beyond genetic factors that could be responsible for" exact="migraine" post="susceptibility and evolution to migraine chronification, epigenetic pathways through"/>
  <result pre="that could be responsible for migraine susceptibility and evolution to" exact="migraine" post="chronification, epigenetic pathways through changes in DNA expression could"/>
  <result pre="research and only a handful of studies are done in" exact="migraine" post="patients. Recently, the first genome-wide study of DNA methylation"/>
  <result pre="methylation levels in episodic migraineurs and patients suffering from chronic" exact="migraine" post="with medication overuse headache (MOH), before and after detox"/>
  <result pre="evolve over time, have been reported by several studies between" exact="migraine" post="patients and controls. The prevalence and volume of deep"/>
  <result pre="and volume of deep white matter lesions is increased in" exact="migraine" post="patients, with women with migraine with aura having the"/>
  <result pre="matter lesions is increased in migraine patients, with women with" exact="migraine" post="with aura having the highest prevalence [ 34– 36]."/>
  <result pre="ARIC MRI study [ 39], the authors showed that although" exact="migraine" post="has an increased insistence of white matter lesions, there"/>
  <result pre="no progression overtime. The authors suggest that the association between" exact="migraine" post="and white matter lesions is stable in older age"/>
  <result pre="of the GWAS on vascular factors that may contribute to" exact="migraine" post="susceptibility, may also suggest an increased susceptibility to white"/>
  <result pre="lesions. A number of studies showed cortical structural changes in" exact="migraine" post="patients (detail reviews can be found here [ 43–"/>
  <result pre="include, increased thickening in the somatosensory cortex of patients with" exact="migraine" post="that does not differ between patients with and without"/>
  <result pre="recent multi-centre 3 T MRI study utilising a large number of" exact="migraine" post="patients [ 53] demonstrated significant clusters of thinner cortex"/>
  <result pre="demonstrated significant clusters of thinner cortex in the patients with" exact="migraine" post="compared with control subjects [ 54]. Gray matter changes"/>
  <result pre="region of the thalamus and a reduced striatal volume in" exact="migraine" post="subjects with and without aura. Studies have shown broad"/>
  <result pre="Studies have shown broad microstructural alterations in the thalamus of" exact="migraine" post="patients that may underlie abnormal cortical excitability. These changes"/>
  <result pre="colleagues demonstrated that structural changes in the brain of episodic" exact="migraine" post="patients without aura evolve over the course of the"/>
  <result pre="migraine patients without aura evolve over the course of the" exact="migraine" post="cycle. Interictally, patients were shown to have a significantly"/>
  <result pre="[ 58]. Whether these changes are an important mechanism of" exact="migraine" post="pathology remains to be evaluated. If indeed these data"/>
  <result pre="correlate with headache frequency assessed in both episodic and chronic" exact="migraine" post="[ 60]. Recently, another study demonstrated alterations in the"/>
  <result pre="the hypothalamus being significantly decreased in both episodic and chronic" exact="migraine" post="patients, which in CM was positively correlated with headache"/>
  <result pre="of these changes. What causes these structural changes in the" exact="migraine" post="brain is not known. Some alterations may be due"/>
  <result pre="alterations may be due to a genetic susceptibility towards developing" exact="migraine" post="attacks. To this end, structural brain studies in paediatric"/>
  <result pre="migraine attacks. To this end, structural brain studies in paediatric" exact="migraine" post="patients, could shed more light in the cause of"/>
  <result pre="showed significant alterations in brain volume. Compared to controls, paediatric" exact="migraine" post="patients experienced a significant gray matter loss in several"/>
  <result pre="gyrus had an increased volume. In the paediatric population of" exact="migraine" post="these structural changes were not correlated with disease duration"/>
  <result pre="apparent diffusion coefficient (ADC) found no volumetric changes in paediatric" exact="migraine" post="patients, but demonstrated increased ADC in the region of"/>
  <result pre="data suggest that brain abnormalities do occur early on in" exact="migraine" post="patients and the absence of correlation with patient clinical"/>
  <result pre="in the migraineur’s brain, their importance in the biology of" exact="migraine" post="remains uncertain. Nevertheless, the existence of structural changes, suggest"/>
  <result pre="remains uncertain. Nevertheless, the existence of structural changes, suggest that" exact="migraine" post="induces progressive anatomical transformation in the brain that may"/>
  <result pre="evolutive role in disease progression and associated disability. The evolutive" exact="migraine" post="attack Migraine is cyclic disorders with a complex sequence"/>
  <result pre="of symptoms within every headache attack. In its episodic form," exact="migraine" post="is characterised by recurrent attacks involving different phases: (a)."/>
  <result pre="mood changes [ 66] (b). Transient neurological symptoms, known as" exact="migraine" post="aura (typically visual alterations), that occur just before the"/>
  <result pre="head, which can be exacerbated by movement and accompanied with" exact="hypersensitivity" post="to sensory stimuli (e.g. light and smells), nausea ["/>
  <result pre="common [ 70]. Significant advances have been made in characterising" exact="migraine" post="as a brain disorder and in identifying evolutive functional"/>
  <result pre="in different brain areas during the different phases of a" exact="migraine" post="attack (Fig. 1). However, despite the number of studies"/>
  <result pre="phase [ 71], the molecular changes that actually trigger a" exact="migraine" post="attack in the brain remain unknown. The lack of"/>
  <result pre="Emerging evidence, partly obtained through use of the newly designed" exact="migraine" post="treatments designed against the calcitonin gene-related peptide (CGRP) and"/>
  <result pre="highlights an important role of the trigeminal system in driving" exact="migraine" post="attacks. Fig. 1 Migraine is cyclic disorders with a"/>
  <result pre="of symptoms within every headache attack. In its episodic form," exact="migraine" post="is characterised by recurrent attacks involving different phases, with"/>
  <result pre="within every phase. Significant advances have been made in characterising" exact="migraine" post="as a brain disorder and in identifying evolutive functional"/>
  <result pre="in different brain areas during the different phases of a" exact="migraine" post="attack The premonitory phase and the triggering mechanisms of"/>
  <result pre="migraine attack The premonitory phase and the triggering mechanisms of" exact="migraine" post="Accumulating evidence exists as to why the trigger of"/>
  <result pre="migraine Accumulating evidence exists as to why the trigger of" exact="migraine" post="attacks should be sought in the hypothalamus. The hypothalamus"/>
  <result pre="hypothalamus, may be also responsible for the monthly, menstrual associated" exact="migraine" post="attacks, and the increased prevalence of migraine in women"/>
  <result pre="monthly, menstrual associated migraine attacks, and the increased prevalence of" exact="migraine" post="in women (~ 3:1) [ 76]. The premonitory symptoms of"/>
  <result pre="migraine in women (~ 3:1) [ 76]. The premonitory symptoms of" exact="migraine" post="are strongly associated with homeostatic functions regulated by the"/>
  <result pre="and feeding. The strongest, direct evidence for hypothalamic activation in" exact="migraine" post="patients arises from brain imaging studies. These studies demonstrated,"/>
  <result pre="of the hypothalamus during the very early stages of spontaneous" exact="migraine" post="attacks [ 77, 78] and during the premonitory phase"/>
  <result pre="and during the premonitory phase of nitroglycerin (nitric oxide-NO donor)-induced" exact="migraine" post="attacks [ 79]. A disturbance in homeostatic function is"/>
  <result pre="as sleep disturbances can trigger attacks in over 50% of" exact="migraine" post="sufferers. Additionally, patients with both episodic and chronic migraine"/>
  <result pre="of migraine sufferers. Additionally, patients with both episodic and chronic" exact="migraine" post="are more prone to have their attacks in the"/>
  <result pre="are also common in patients with sleep disorders, while post-operative" exact="migraine" post="attacks in patients are common following anaesthesia [ 81]."/>
  <result pre="called familiar advanced sleep phase syndrome, was strongly linked to" exact="migraine" post="both clinically and experimentally in mice engineered to carry"/>
  <result pre="to carry this mutation [ 83]. The increased comorbidity of" exact="migraine" post="in narcolepsy [ 84] and sleepwalking [ 85], also"/>
  <result pre="this mutation [ 83]. The increased comorbidity of migraine in" exact="narcolepsy" post="[ 84] and sleepwalking [ 85], also supports that"/>
  <result pre="narcolepsy [ 84] and sleepwalking [ 85], also supports that" exact="migraine" post="is an arousal-related disorder. Such evidence highlights that the"/>
  <result pre="been investigated. Although several neurochemical pathways may be involved in" exact="migraine" post="pathophysiology [ 86], of them, dopaminergic mechanisms appear to"/>
  <result pre="be susceptible to nitric oxide donors in animal models of" exact="migraine" post="[ 90, 91]. Of interest, an fMRI study of"/>
  <result pre="interest, an fMRI study of daily brain scans in a" exact="migraine" post="patient reported a strong association for both hypothalamic and"/>
  <result pre="attack [ 78]. The involvement of the occipital cortex in" exact="migraine" post="has been long recognised, in particular because of the"/>
  <result pre="hyperactive [ 92, 93]. A study of photophobia during spontaneous" exact="migraine" post="attacks using PET imaging also found that this migraine"/>
  <result pre="spontaneous migraine attacks using PET imaging also found that this" exact="migraine" post="symptom is linked with visual cortex hyperexcitability [ 94,"/>
  <result pre="94, 95]. It has been suggested that thalamo-cortical dysrhythmia in" exact="migraine" post="patients may be responsible for abnormal cortical responses ["/>
  <result pre="cortical responses [ 96]. Hence, a focal cortical treatment for" exact="migraine" post="without systemic side effects is an attractive treatment opportunity."/>
  <result pre="ascending trigemino-thalamic pathway [ 97] and is now an approved" exact="migraine" post="treatment with good efficacy in the acute and preventive"/>
  <result pre="with good efficacy in the acute and preventive treatment of" exact="migraine" post="[ 98– 100]. The migraine aura Migraine with aura"/>
  <result pre="acute and preventive treatment of migraine [ 98– 100]. The" exact="migraine" post="aura Migraine with aura symptoms are typically seen in"/>
  <result pre="fMRI studies that tried to capture or simulate aura in" exact="migraine" post="patients also pointed to a role for CSD as"/>
  <result pre="pointed to a role for CSD as a mechanism for" exact="migraine" post="aura [ 103, 104]. CSD is a wave of"/>
  <result pre="neuronal activity and blood flow changes [ 105], which in" exact="migraine" post="is believed to spread out from the occipital cortex."/>
  <result pre="It remains enigmatic how CSD is triggered in patients during" exact="migraine" post="aura. Potentially, if indeed cortex is hyperactive in patients,"/>
  <result pre="for the cortex and this has also been recorded in" exact="migraine" post="patients without aura [ 102]. The discussion of CSD-induced"/>
  <result pre="without aura [ 102]. The discussion of CSD-induced headache in" exact="migraine" post="is still a matter of debate, as not every"/>
  <result pre="migraine is still a matter of debate, as not every" exact="migraine" post="patient experiences migraine aura, while the occurrence of aura"/>
  <result pre="a matter of debate, as not every migraine patient experiences" exact="migraine" post="aura, while the occurrence of aura without a headache"/>
  <result pre="pathway [ 115]. The headache phase The headache phase of" exact="migraine" post="involves activation of the ascending trigeminothalamic pathway. Through early"/>
  <result pre="surgery, it became well established that the pain during a" exact="migraine" post="attack is perceived to be felt on intracranial structures,"/>
  <result pre="the thalamus and pain modulating/pain encoding cortical areas during spontaneous" exact="migraine" post="attacks, as well as, thalamo-cortical dysrhythmia which correlate with"/>
  <result pre="migraine attacks, as well as, thalamo-cortical dysrhythmia which correlate with" exact="migraine" post="symptoms [ 121, 122]. Recently, a dynamic functional connectivity"/>
  <result pre="[ 121, 122]. Recently, a dynamic functional connectivity study in" exact="migraine" post="patients between attacks demonstrated abnormal thalamo-cortical network dynamics, with"/>
  <result pre="connectivity networks [ 123]. The role of the thalamus in" exact="migraine" post="deserves higher attention given its involvement in the development"/>
  <result pre="its involvement in the development of associated symptoms, such as" exact="hypersensitivity" post="to visual stimuli [ 124], while thalamo-cortical activation may"/>
  <result pre="the development of non-cranial allodynia that is frequently seen in" exact="migraine" post="patients [ 126]. A complex of descending networks from"/>
  <result pre="and brainstem in both episodic [ 128, 129] and chronic" exact="migraine" post="patients [ 130]. A great limitation of brain imaging"/>
  <result pre="nucleus raphe magnus. Initially, these loci were considered as the" exact="migraine" post="generator, due to the persistent blood flow increased in"/>
  <result pre="of pain inhibition in migraineurs [ 53]. The puzzle of" exact="migraine" post="pathophysiology is still incomplete, as we are yet to"/>
  <result pre="(CSD) is thought to be the biological process of the" exact="migraine" post="aura. How activation of the hypothalamus may lead to"/>
  <result pre="brainstem, or the parasympathetic system, leading to the development of" exact="migraine" post="aura and activation of the ascending trigeminothalamic pathway An"/>
  <result pre="equally important pathway may be the trigeminal autonomic activation in" exact="migraine" post="driven by the hypothalamus. Although autonomic features in migraine"/>
  <result pre="in migraine driven by the hypothalamus. Although autonomic features in" exact="migraine" post="are not as prominent as in trigeminal autonomic cephalalgias,"/>
  <result pre="and the otic ganglia [ 133]. Sphenopalatine ganglion block in" exact="migraine" post="patients with autonomic features was found to relieve the"/>
  <result pre="modulation of the trigeminal autonomic reflex by the hypothalamus in" exact="migraine" post="may be of great importance. The trigeminal system and"/>
  <result pre="system and its role in sustaining the head pain in" exact="migraine" post="Despite the various evidence of increased blood flow changes"/>
  <result pre="of the ascending trigemino-thalamic pathway in a manner that a" exact="migraine" post="headache may develop in susceptible individuals remains to be"/>
  <result pre="importance in driving the headache; The referred pain patterns of" exact="migraine" post="headache are similar to the locations of referred pain"/>
  <result pre="vast innervation by trigeminal fibres. CGRP levels are increased during" exact="migraine" post="attacks. Blood samples from patients or animal models during"/>
  <result pre="fibres suggest that the origin of the CGRP found in" exact="migraine" post="patients is indeed from the trigeminal nerve [ 139–"/>
  <result pre="145– 147], such as CGRP and histamine, can trigger a" exact="migraine" post="attack [ 148, 149]. It is worth pointing out"/>
  <result pre="the pain is not vasodilation as originally thought, as the" exact="migraine" post="headache is not associated with cerebral or meningeal vasodilation"/>
  <result pre="not susceptible (or respond to a much lower degree) to" exact="migraine" post="headache following provocation with such chemicals, suggesting that the"/>
  <result pre="provocation with such chemicals, suggesting that the trigeminal system in" exact="migraine" post="patients is sensitized. Effective migraine treatments, like the hydrophilic"/>
  <result pre="that the trigeminal system in migraine patients is sensitized. Effective" exact="migraine" post="treatments, like the hydrophilic sumatriptan, the large monoclonal antibodies"/>
  <result pre="demonstrate an important role for the peripheral trigeminal system in" exact="migraine" post="headache. This evidence further suggests that treatments that can"/>
  <result pre="effective in suppressing migraine, but not necessarily the generator of" exact="migraine" post="attacks. The trigeminal system, as well as, the trigemino-thalamic"/>
  <result pre="the major excitatory neurotransmitter [ 120]. An ideal treatment for" exact="migraine" post="would block the glutamatergic transmission along these pathways, as"/>
  <result pre="more promising treatment approach [ 155, 156]. Vascular changes in" exact="migraine" post="Vascular changes in migraine were for a long time"/>
  <result pre="[ 155, 156]. Vascular changes in migraine Vascular changes in" exact="migraine" post="were for a long time considered the driver of"/>
  <result pre="migraine were for a long time considered the driver of" exact="migraine" post="pain. In 1940 Ray and Wolff reported that stimulation"/>
  <result pre="A 3 T magnetic resonance angiography (MRA) study during a spontaneous" exact="migraine" post="attack showed no significant changes of the diameter of"/>
  <result pre="the diameter of middle meningeal artery (MMA) during a spontaneous" exact="migraine" post="attack [ 158], however a larger study in cilostazol-induced"/>
  <result pre="migraine attack [ 158], however a larger study in cilostazol-induced" exact="migraine" post="attacks, found that the onset of migraine is associated"/>
  <result pre="study in cilostazol-induced migraine attacks, found that the onset of" exact="migraine" post="is associated with increase in MMA circumference specific to"/>
  <result pre="to the headache side [ 159]. In different studies in" exact="migraine" post="patients with unilateral headache, headache was associated with intracranial"/>
  <result pre="the temporal artery [ 161]. Spontaneous dilatation alone cannot explain" exact="migraine" post="pain, as arteries may dilate markedly, such as during"/>
  <result pre="such as during blood pressure decreases, without induction of a" exact="migraine" post="attack. In a nitroglycerin-triggered migraine study, peak dilation of"/>
  <result pre="decreases, without induction of a migraine attack. In a nitroglycerin-triggered" exact="migraine" post="study, peak dilation of the MCA occurred during the"/>
  <result pre="MCA occurred during the infusion phase of nitroglycerin. However, a" exact="migraine" post="attack fulfilling the International Headache Society diagnostic criteria occurred"/>
  <result pre="role of the cGMP pathway in the development of a" exact="migraine" post="attack, rather than the vasodilation itself. These evidences suggest"/>
  <result pre="mechanical dilatation is not adequate to activate nociceptors and cause" exact="migraine" post="headache [ 162], and indeed, migraine can be induced,"/>
  <result pre="activate nociceptors and cause migraine headache [ 162], and indeed," exact="migraine" post="can be induced, e.g. by sildenafil, without initial dilatation"/>
  <result pre="of genomic loci identified in GWAS to be associated with" exact="migraine" post="without aura are involved in pathways associated with vascular"/>
  <result pre="still be possible that blood vessels play a role in" exact="migraine" post="pathophysiology in the absence of vasodilation. The postdrome phase"/>
  <result pre="the absence of vasodilation. The postdrome phase About 80% of" exact="migraine" post="patients report at least one non-headache symptom following the"/>
  <result pre="headache, while the disability scores remain high [ 69]. The" exact="migraine" post="postdrome is the least studied and least understood phase"/>
  <result pre="the occipital cortex [ 78, 165]. The evolutive process of" exact="migraine" post="chronification Chronic migraine (CM) is a disabling, underdiagnosed and"/>
  <result pre="[ 78, 165]. The evolutive process of migraine chronification Chronic" exact="migraine" post="(CM) is a disabling, underdiagnosed and undertreated disorder, affecting"/>
  <result pre="general population [ 166, 167]. Progression from episodic to chronic" exact="migraine" post="is a clinical reality [ 168, 169]. Studies show"/>
  <result pre="168, 169]. Studies show that each year 2.5% of episodic" exact="migraine" post="patients progress into chronic migraine [ 170] which appears"/>
  <result pre="each year 2.5% of episodic migraine patients progress into chronic" exact="migraine" post="[ 170] which appears as a distinct entity in"/>
  <result pre="entity in the classification of the International Headache Society (chronic" exact="migraine" post="&amp;gt; 15 migraine days per month) [ 68]. The nosology"/>
  <result pre="the classification of the International Headache Society (chronic migraine &amp;gt; 15" exact="migraine" post="days per month) [ 68]. The nosology of CM"/>
  <result pre="risk factors have been identified to double the risk for" exact="migraine" post="chronification [ 172], including de novo increased migraine attack"/>
  <result pre="risk for migraine chronification [ 172], including de novo increased" exact="migraine" post="attack frequency and overuse of acute migraine medications ["/>
  <result pre="de novo increased migraine attack frequency and overuse of acute" exact="migraine" post="medications [ 173– 175], ineffective acute treatment that could"/>
  <result pre="and lifestyle factors such as stress, high caffeine intake and" exact="obesity" post="[ 173, 178]. Certainly, either genetic factors or the"/>
  <result pre="of patients. In a recent resting-state fMRI study in chronic" exact="migraine" post="patients without medication overuse it was shown that CM"/>
  <result pre="unknow. The physiological mechanisms that underlie the development of chronic" exact="migraine" post="from its episodic form are not understood. Cortical excitability"/>
  <result pre="not understood. Cortical excitability appears to be abnormal in chronic" exact="migraine" post="patients, but this could be a consequence of the"/>
  <result pre="chronic migraine. Inflammation and central sensitization in the pathophysiology of" exact="migraine" post="chronification The question whether inflammation could contribute in the"/>
  <result pre="the trigeminal system in a manner that could drive the" exact="migraine" post="headache and be implicated in the evolutive process of"/>
  <result pre="migraine headache and be implicated in the evolutive process of" exact="migraine" post="chronification remains relevant in migraine pathophysiology and treatment ["/>
  <result pre="in the evolutive process of migraine chronification remains relevant in" exact="migraine" post="pathophysiology and treatment [ 187]. Indeed, the broad use"/>
  <result pre="the involvement of some neuroimmune responses in the development of" exact="migraine" post="[ 188, 189], while steroid injections in the region"/>
  <result pre="nerve, are widely used as a preventive method in chronic" exact="migraine" post="[ 190, 191]. In animals, sustained CGRP release may"/>
  <result pre="and cells of immune system [ 193– 195]. During a" exact="migraine" post="attack that can last for up to 72 h, the"/>
  <result pre="to be involved in the initiation and progression of a" exact="migraine" post="attack [ 198]. Studies have demonstrated changes in plasma,"/>
  <result pre="changes in plasma, serum, or urine levels of TNF-α in" exact="migraine" post="patients during attacks and attack free intervals [ 199,"/>
  <result pre="and coworkers reported that mRNA expression of TNF-α increased following" exact="migraine" post="induction in animal models [ 201]. Elevated TNF-α serum"/>
  <result pre="outside of attacks, confirm a possible role of TNF-α in" exact="migraine" post="[ 202]. A direct pathogenic role of TNF-α has"/>
  <result pre="MC/UC. Considering the very high prevalence of migraine, several hundred-thousand" exact="migraine" post="patients must have received TNF-α antibody but there are"/>
  <result pre="antibody but there are no reports on any prevention of" exact="migraine" post="attacks, not even in case-reports. This suggests that preventing"/>
  <result pre="long-term activation of the TG, serving as a model of" exact="migraine" post="chronification [ 206] and activation of the trigeminal nucleus"/>
  <result pre="CGRP in nociceptive neurons and could participate in generating pain" exact="hypersensitivity" post="[ 208]. Looking further into in vivo inflammation, administration"/>
  <result pre="occur if indeed the trigeminal system is sustainably activated during" exact="migraine" post="attacks, could lead to the development of central sensitization."/>
  <result pre="intestinal peptide (VIP) are higher in chronic than in episodic" exact="migraine" post="[ 212– 214]. Additionally, in animal models it has"/>
  <result pre="neuronal basis for persistent pain and &quot;pain memory&quot; in chronic" exact="migraine" post="[ 220– 222]. Central sensitization is a glutamate-dependent process"/>
  <result pre="fibres innervating the dura matter [ 223]. Indeed, during a" exact="migraine" post="headache about 80% of migraine patients develop cutaneous allodynia,"/>
  <result pre="[ 223]. Indeed, during a migraine headache about 80% of" exact="migraine" post="patients develop cutaneous allodynia, characterised by increased skin sensitivity,"/>
  <result pre="thirds of the patients developing cutaneous allodynia report that untreated" exact="migraine" post="attacks will result in a spread of allodynia to"/>
  <result pre="development of central sensitization and the susceptibility in developing chronic" exact="migraine" post="could be a dysfunction in pain modulating systems. An"/>
  <result pre="of sensitization and could contribute to the development of chronic" exact="migraine" post="[ 230, 231]. What is interesting though, is that"/>
  <result pre="static and evolve continuously. During lifespan the clinical phenotype of" exact="migraine" post="changes. These changes may include transformation from episodic to"/>
  <result pre="changes. These changes may include transformation from episodic to chronic" exact="migraine" post="or even a disappearance of some or all migraine"/>
  <result pre="chronic migraine or even a disappearance of some or all" exact="migraine" post="symptoms all together. Genetic and epigenetic susceptibility may be"/>
  <result pre="light on how such genetic alterations may be responsible for" exact="migraine" post="pathophysiology or any evolutive mechanism. On the other hand,"/>
  <result pre="the other hand, anatomical changes in the brain of a" exact="migraine" post="patient exist even from early childhood, but they do"/>
  <result pre="causality dilemma of whether such changes are responsible for how" exact="migraine" post="evolves, or whether migraine mechanisms drive these anatomic changes,"/>
  <result pre="such changes are responsible for how migraine evolves, or whether" exact="migraine" post="mechanisms drive these anatomic changes, remains to be answered."/>
  <result pre="changes, remains to be answered. Even in its episodic form," exact="migraine" post="is an evolutive condition with different mechanisms involved in"/>
  <result pre="with different mechanisms involved in the evolutive process of a" exact="migraine" post="attack. These mechanisms include hypothalamic alterations during the premonitory"/>
  <result pre="phase, and potential cortical changes during the postdrome phase. How" exact="migraine" post="headache is triggered following hypothalamic activation remains unknown. A"/>
  <result pre="brain-initiated event. The mechanisms that underlie the development of chronic" exact="migraine" post="from its episodic form are not well understood. Several"/>
  <result pre="Several factors have been identified to increase the risk for" exact="migraine" post="chronification. Inflammation and central sensitization play a significant role"/>
  <result pre="the evolutive mechanisms of chronic migraine. The continuous changes in" exact="migraine" post="phenotype and pathophysiology during a migraine attack between episodic"/>
  <result pre="The continuous changes in migraine phenotype and pathophysiology during a" exact="migraine" post="attack between episodic and chronic migraine and during the"/>
  <result pre="and pathophysiology during a migraine attack between episodic and chronic" exact="migraine" post="and during the patient lifespan, make migraine, even in"/>
  <result pre="J Lipton RB The prevalence and disability burden of adult" exact="migraine" post="in England and their relationships to age, gender and"/>
  <result pre="Peres FM Silberstein SD Stiles MA Young WB Epidemiology of" exact="migraine" post="Atlas of migraine and other headaches 2005 2 London"/>
  <result pre="SD Stiles MA Young WB Epidemiology of migraine Atlas of" exact="migraine" post="and other headaches 2005 2 London and New York"/>
  <result pre="P Olesen J Prevalence and sex-ratio of the subtypes of" exact="migraine" post="Int J Epidemiol 1995 24 3 612 618 10.1093/ije/24.3.612"/>
  <result pre="Evers S et al. Regional variations in the prevalence of" exact="migraine" post="and tension-type headache applying the new IHS criteria: the"/>
  <result pre="15. Maytal J Young M Shechter A Lipton RB Pediatric" exact="migraine" post="and the international headache society (IHS) criteria Neurology. 1997"/>
  <result pre="Eidlitz-Markus T Gorali O Haimi-Cohen Y Zeharia A Symptoms of" exact="migraine" post="in the paediatric population by age group Cephalalgia. 2008"/>
  <result pre="AA Reider AC Goadsby PJ Cranial autonomic symptoms in pediatric" exact="migraine" post="are the rule, not the exception Neurology. 2013 81"/>
  <result pre="al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for" exact="migraine" post="Nat Genet 2016 48 8 856 866 10.1038/ng.3598 27322543"/>
  <result pre="of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with" exact="familial hemiplegic migraine" post="type 2 Nat Genet 2003 33 2 192 196"/>
  <result pre="encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic" exact="migraine" post="type 2 Nat Genet 2003 33 2 192 196"/>
  <result pre="al. Mutation in the neuronal voltage-gated sodium channel SCN1A in" exact="familial hemiplegic migraine" post="Lancet. 2005 366 9483 371 377 10.1016/S0140-6736(05)66786-4 16054936 28."/>
  <result pre="in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic" exact="migraine" post="Lancet. 2005 366 9483 371 377 10.1016/S0140-6736(05)66786-4 16054936 28."/>
  <result pre="S Broos LA Cesetti T et al. A Cacna1a knockin" exact="migraine" post="mouse model with increased susceptibility to cortical spreading depression"/>
  <result pre="al. Differential trigeminovascular nociceptive responses in the thalamus in the" exact="familial hemiplegic migraine" post="1 knock-in mouse: a Fos protein study Neurobiol Dis"/>
  <result pre="trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic" exact="migraine" post="1 knock-in mouse: a Fos protein study Neurobiol Dis"/>
  <result pre="of calcitonin gene-related peptide in the trigeminal system of the" exact="familial hemiplegic migraine" post="1 knock-in mouse Cephalalgia. 2011 31 13 1368 1380"/>
  <result pre="gene-related peptide in the trigeminal system of the familial hemiplegic" exact="migraine" post="1 knock-in mouse Cephalalgia. 2011 31 13 1368 1380"/>
  <result pre="methylation profiling in whole blood reveals epigenetic signatures associated with" exact="migraine" post="BMC Genomics 2018 19 1 69 10.1186/s12864-018-4450-2 29357833 33."/>
  <result pre="et al. Epigenetic DNA methylation changes in episodic and chronic" exact="migraine" post="Neurol Sci 2018 39 Suppl 1 67 68 10.1007/s10072-018-3348-8"/>
  <result pre="al. Microstructural white matter changes preceding white matter hyperintensities in" exact="migraine" post="Neurology 2019 93 7 e688 e694 10.1212/WNL.0000000000007940 31296653 38."/>
  <result pre="Konishi J Moonen JM et al. Structural brain changes in" exact="migraine" post="JAMA. 2012 308 18 1889 1897 10.1001/jama.2012.14276 23150008 39."/>
  <result pre="Ba-Ssalamah A Schoder M et al. Virchow-Robin spaces in childhood" exact="migraine" post="Neuroradiology. 1999 41 4 283 287 10.1007/s002340050749 10344516 41."/>
  <result pre="Structural changes in the cerebrum, cerebellum and Corpus callosum in" exact="migraine" post="patients Clin Invest Med 2016 39 6 27495 10.25011/cim.v39i6.27495"/>
  <result pre="et al. Structural and functional reorganization of the brain in" exact="migraine" post="without aura Front Neurol 2019 10 442 10.3389/fneur.2019.00442 31133962"/>
  <result pre="Hadjikhani N Thickening in the somatosensory cortex of patients with" exact="migraine" post="Neurology. 2007 69 21 1990 1995 10.1212/01.wnl.0000291618.32247.2d 18025393 50."/>
  <result pre="T Bogdahn U May A Subtle grey matter changes between" exact="migraine" post="patients and healthy controls Cephalalgia. 2008 28 1 1"/>
  <result pre="magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in" exact="migraine" post="Annals of Neurology 2011 70 5 838 845 10.1002/ana.22537"/>
  <result pre="Frakes DH Schwedt TJ Structural alterations of the brainstem in" exact="migraine" post="Neuroimage Clin 2017 13 223 227 10.1016/j.nicl.2016.10.023 28003961 58."/>
  <result pre="C et al. Evidence for brain morphometric changes during the" exact="migraine" post="cycle: a magnetic resonance-based morphometry study Cephalalgia. 2015 35"/>
  <result pre="Volumetric differences suggest involvement of cerebellum and brainstem in chronic" exact="migraine" post="Cephalalgia. 2016 36 4 301 308 10.1177/0333102415588328 26002699 60."/>
  <result pre="S Volume of hypothalamus as a diagnostic biomarker of chronic" exact="migraine" post="Front Neurol 2019 10 606 10.3389/fneur.2019.00606 31244765 63. Rocca"/>
  <result pre="Filippi M Structural brain MRI abnormalities in pediatric patients with" exact="migraine" post="J Neurol 2014 261 2 350 357 10.1007/s00415-013-7201-y 24305994"/>
  <result pre="of headache disorders 3rd edition beta-based field testing of vestibular" exact="migraine" post="in China: demographic, clinical characteristics, audiometric findings and diagnosis"/>
  <result pre="NJ Lipton RB Silberstein SD Olesen J Goadsby PJ The" exact="migraine" post="postdrome: an electronic diary study Neurology. 2016 87 3"/>
  <result pre="70. Kelman L The triggers or precipitants of the acute" exact="migraine" post="attack Cephalalgia. 2007 27 5 394 402 10.1111/j.1468-2982.2007.01303.x 17403039"/>
  <result pre="Charbit A Andreou A Akerman S Holland P Neurobiology of" exact="migraine" post="Neuroscience. 2009 161 2 327 341 10.1016/j.neuroscience.2009.03.019 19303917 72."/>
  <result pre="G Andreou AP Guglielmetti M Martelletti P Emerging drugs for" exact="migraine" post="treatment: an update Expert Opin Emerg Drugs 2018 23"/>
  <result pre="75. Alstadhaug KB Salvesen R Bekkelund SI Seasonal variation in" exact="migraine" post="Cephalalgia. 2005 25 10 811 816 10.1111/j.1468-2982.2005.01018.x 16162258 76."/>
  <result pre="Payoux P Chollet F Geraud G Hypothalamic activation in spontaneous" exact="migraine" post="attacks Headache. 2007 47 10 1418 1426 18052951 78."/>
  <result pre="10 1418 1426 18052951 78. Schulte LH May A The" exact="migraine" post="generator revisited: continuous scanning of the migraine cycle over"/>
  <result pre="May A The migraine generator revisited: continuous scanning of the" exact="migraine" post="cycle over 30 days and three spontaneous attacks Brain."/>
  <result pre="Goadsby PJ Brain activations in the premonitory phase of nitroglycerin-triggered" exact="migraine" post="attacks Brain. 2014 137 Pt 1 232 241 10.1093/brain/awt320"/>
  <result pre="hypothesis for multiple triggers of the pain and strain of" exact="migraine" post="J Comp Neurol 2005 493 1 9 14 10.1002/cne.20688"/>
  <result pre="Huang Y et al. Casein kinase idelta mutations in familial" exact="migraine" post="and advanced sleep phase Sci Transl Med 2013 5"/>
  <result pre="S Gencik M Epplen JT Ullrich B Increased frequency of" exact="migraine" post="in narcoleptic patients: a confirmatory study Cephalalgia. 2003 23"/>
  <result pre="Palmer JE Koehler PJ Vredeveld JW Visual cortex excitability in" exact="migraine" post="with and without aura Headache. 2001 41 6 565"/>
  <result pre="Y Geraud G A PET study of photophobia during spontaneous" exact="migraine" post="attacks Neurology. 2011 76 3 213 218 10.1212/WNL.0b013e3182074a57 21148120"/>
  <result pre="KC Turn down the lights!: an irritable occipital cortex in" exact="migraine" post="without aura Neurology. 2011 76 3 206 207 10.1212/WNL.0b013e3182074bfb"/>
  <result pre="Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in" exact="migraine" post="Brain. 2016 139 Pt 7 2002 2014 10.1093/brain/aww118 27246325"/>
  <result pre="et al. Single-pulse transcranial magnetic stimulation for acute treatment of" exact="migraine" post="with aura: a randomised, double-blind, parallel-group, sham-controlled trial Lancet"/>
  <result pre="prospective, single arm, open label, observational study of sTMS for" exact="migraine" post="prevention (ESPOUSE study) Cephalalgia. 2018 38 6 1038 1048"/>
  <result pre="29504483 101. Rasmussen BK Olesen J Migraine with aura and" exact="migraine" post="without aura: an epidemiological study Cephalalgia. 1992 12 4"/>
  <result pre="Olesen J Regional cerebral blood flow and oxygen metabolism during" exact="migraine" post="with and without aura Cephalalgia. 1998 18 1 2"/>
  <result pre="K Vestergaard MB Schytz HW Amin FM et al. Heterogenous" exact="migraine" post="aura symptoms correlate with visual cortex functional magnetic resonance"/>
  <result pre="Schwartz D Bakker D Fischl B et al. Mechanisms of" exact="migraine" post="aura revealed by functional MRI in human visual cortex"/>
  <result pre="MA Intrinsic brain activity triggers trigeminal meningeal afferents in a" exact="migraine" post="model Nat Med 2002 8 2 136 142 10.1038/nm0202-136"/>
  <result pre="Activation of meningeal nociceptors by cortical spreading depression: implications for" exact="migraine" post="with aura J Neurosci 2010 30 26 8807 8814"/>
  <result pre="between spreading depression, neurogenic inflammation, and nociception that might cause" exact="migraine" post="headache? Ann Neurol 2001 49 1 7 13 10.1002/1531-8249(200101)49:1&amp;lt;7::AID-ANA4&amp;gt;3.0.CO;2-K"/>
  <result pre="cortical spreading depression- unraveling a new central mechanism involved in" exact="migraine" post="aura J Headache Pain 2013 14 16 10.1186/1129-2377-14-S1-I6 23565801"/>
  <result pre="receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a" exact="migraine" post="target? Neurobiol Dis 2006 23 3 491 501 10.1016/j.nbd.2006.04.003"/>
  <result pre="Goadsby PJ Therapeutic potential of novel glutamate receptor antagonists in" exact="migraine" post="Expert Opin Investig Drugs 2009 18 6 789 803"/>
  <result pre="E et al. Altered thalamic connectivity during spontaneous attacks of" exact="migraine" post="without aura: a resting-state fMRI study Cephalalgia. 2018 38"/>
  <result pre="L Li Z et al. Abnormal thalamocortical network dynamics in" exact="migraine" post="Neurology. 2019 92 23 e2706 e2e16 10.1212/WNL.0000000000007607 31076535 124."/>
  <result pre="S Holland PR Goadsby PJ Diencephalic and brainstem mechanisms in" exact="migraine" post="Nat Rev Neurosci 2011 12 10 570 584 10.1038/nrn3057"/>
  <result pre="Schayck RV et al. Brain stem activation in spontaneous human" exact="migraine" post="attacks Nat Med 1995 1 7 658 660 10.1038/nm0795-658"/>
  <result pre="RS et al. A positron emission tomographic study in spontaneous" exact="migraine" post="Arch Neurol 2005 62 8 1270 1275 10.1001/archneur.62.8.1270 16087768"/>
  <result pre="Frackowiak RS Weiner R Goadsby PJ Central neuromodulation in chronic" exact="migraine" post="patients with suboccipital stimulators: a PET study Brain. 2004"/>
  <result pre="A PET study exploring the laterality of brainstem activation in" exact="migraine" post="using glyceryl trinitrate Brain. 2005 128 Pt 4 932"/>
  <result pre="award: possible parasympathetic contributions to peripheral and central sensitization during" exact="migraine" post="Headache. 2003 43 7 704 714 10.1046/j.1526-4610.2003.03127.x 12890124 135."/>
  <result pre="Vasoactive peptide release in the extracerebral circulation of humans during" exact="migraine" post="headache Ann Neurol 1990 28 2 183 187 10.1002/ana.410280213"/>
  <result pre="integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced" exact="migraine" post="Brain. 2016 139 Pt 7 1994 2001 10.1093/brain/aww096 27234268"/>
  <result pre="brainstem perfusion, but no blood-brain barrier disruption, during attacks of" exact="migraine" post="with aura Brain. 2017 140 6 1633 1642 10.1093/brain/awx089"/>
  <result pre="B Olesen J CGRP may play a causative role in" exact="migraine" post="Cephalalgia. 2002 22 1 54 61 10.1046/j.1468-2982.2002.00310.x 11993614 149."/>
  <result pre="11993614 149. Lassen LH Thomsen LL Olesen J Histamine induces" exact="migraine" post="via the H1-receptor. Support for the NO hypothesis of"/>
  <result pre="migraine via the H1-receptor. Support for the NO hypothesis of" exact="migraine" post="Neuroreport. 1995 6 11 1475 1479 10.1097/00001756-199507310-00003 7579128 150."/>
  <result pre="C et al. Prospective real-world analysis of OnabotulinumtoxinA in chronic" exact="migraine" post="post-National Institute for health and care excellence UK technology"/>
  <result pre="153. Dodick DW CGRP ligand and receptor monoclonal antibodies for" exact="migraine" post="prevention: evidence review and clinical implications Cephalalgia. 2019 39"/>
  <result pre="Yanagimachi N Takagi S The middle meningial artery during a" exact="migraine" post="attack: 3T magnetic resonance angiography study Intern Med 2009"/>
  <result pre="H Younis S Olinger ACR et al. Meningeal contribution to" exact="migraine" post="pain: a magnetic resonance angiography study Brain. 2019 142"/>
  <result pre="HK Nielsen TH Olesen J Tfelt-Hansen P Arterial responses during" exact="migraine" post="headache Lancet. 1990 336 8719 837 839 10.1016/0140-6736(90)92339-J 1976878"/>
  <result pre="162. Ashina M Vascular changes have a primary role in" exact="migraine" post="Cephalalgia. 2012 32 5 428 430 10.1177/0333102412438978 22523234 163."/>
  <result pre="130 144 10.1016/j.neuroscience.2016.06.012 27312704 165. Bose P Goadsby PJ The" exact="migraine" post="postdrome Curr Opin Neurol 2016 29 3 299 301"/>
  <result pre="KM Serrano D Reed ML Turkel CC et al. Chronic" exact="migraine" post="prevalence, disability, and sociodemographic factors: results from the American"/>
  <result pre="F D'Amico D Schieroni F Bussone G Neurobiology of chronic" exact="migraine" post="Neurol Sci 2003 24 Suppl 2 S94 S96 10.1007/s100720300051"/>
  <result pre="S94 S96 10.1007/s100720300051 12811602 169. Lipton RB Pan J Is" exact="migraine" post="a progressive brain disease? JAMA. 2004 291 4 493"/>
  <result pre="171. Mathew NT Reuveni U Perez F Transformed or evolutive" exact="migraine" post="Headache. 1987 27 2 102 106 10.1111/j.1526-4610.1987.hed2702102.x 3570762 172."/>
  <result pre="and predictors for chronicity of headache in patients with episodic" exact="migraine" post="Neurology. 2004 62 5 788 790 10.1212/01.WNL.0000113747.18760.D2 15007133 176."/>
  <result pre="ML Cady R Buse DC Ineffective acute treatment of episodic" exact="migraine" post="is associated with new-onset chronic migraine Neurology. 2015 84"/>
  <result pre="acute treatment of episodic migraine is associated with new-onset chronic" exact="migraine" post="Neurology. 2015 84 7 688 695 10.1212/WNL.0000000000001256 25609757 177."/>
  <result pre="al. Depression and risk of transformation of episodic to chronic" exact="migraine" post="J Headache Pain 2012 13 8 615 624 10.1007/s10194-012-0479-9"/>
  <result pre="ME Lipton RB Obesity is a risk factor for transformed" exact="migraine" post="but not chronic tension-type headache Neurology. 2006 67 2"/>
  <result pre="Quantitative MRI studies of chronic brain white matter hyperintensities in" exact="migraine" post="patients Headache. 2013 53 5 752 763 10.1111/head.12013 23278630"/>
  <result pre="L Ferraro S Grazzi L Bussone G Neuroimaging in chronic" exact="migraine" post="Neurol Sci 2010 31 Suppl 1 S19 S22 10.1007/s10072-010-0266-9"/>
  <result pre="tesla shows subtle cerebral grey matter abnormalities in patients with" exact="migraine" post="J Neurol Neurosurg Psychiatry 2006 77 5 686 689"/>
  <result pre="M Pinessi L Voxel-based morphometry reveals gray matter abnormalities in" exact="migraine" post="Headache. 2008 48 1 109 117 10.1111/j.1526-4610.2007.00723.x 18184293 184."/>
  <result pre="W Qi W et al. White matter lesions in chronic" exact="migraine" post="with medication overuse headache: a cross-sectional MRI study J"/>
  <result pre="24535135 185. Coppola G Schoenen J Cortical excitability in chronic" exact="migraine" post="Curr Pain Headache Rep 2012 16 1 93 100"/>
  <result pre="Moskowitz MA Neurogenic inflammation in the pathophysiology and treatment of" exact="migraine" post="Neurology. 1993 43 6 Suppl 3 S16 S20 8389008"/>
  <result pre="H Han W Wang J Li M Network meta-analysis of" exact="migraine" post="disorder treatment by NSAIDs and triptans J Headache Pain"/>
  <result pre="Mookadam M Greater occipital nerve block for acute treatment of" exact="migraine" post="headache: a large retrospective cohort study J Am Board"/>
  <result pre="of greater occipital nerve block on severity and frequency of" exact="migraine" post="headache Global J Health Sci 2014 6 6 209"/>
  <result pre="Wilkins 309 319 198. Pietrobon D Moskowitz MA Pathophysiology of" exact="migraine" post="Annu Rev Physiol 2013 75 365 391 10.1146/annurev-physiol-030212-183717 23190076"/>
  <result pre="Are TNF-alpha and IL-1 beta relevant in the pathogenesis of" exact="migraine" post="without aura? Acta Neurol (Napoli) 1991 13 2 205"/>
  <result pre="inflammatory potential of trigeminal ganglia in a mouse model of" exact="familial hemiplegic migraine" post="PLoS One 2013 8 1 e52394 10.1371/journal.pone.0052394 23326332 202."/>
  <result pre="of trigeminal ganglia in a mouse model of familial hemiplegic" exact="migraine" post="PLoS One 2013 8 1 e52394 10.1371/journal.pone.0052394 23326332 202."/>
  <result pre="Domingues RB Increased serum levels of brain-derived neurotropic factor during" exact="migraine" post="attacks: a pilot study J Headache Pain 2010 11"/>
  <result pre="C Pascual J Increased VIP levels in peripheral blood outside" exact="migraine" post="attacks as a potential biomarker of cranial parasympathetic activation"/>
  <result pre="as a potential biomarker of cranial parasympathetic activation in chronic" exact="migraine" post="Cephalalgia. 2015 35 4 310 316 10.1177/0333102414535111 24847167 213."/>
  <result pre="CGRP levels in peripheral blood as a biomarker for chronic" exact="migraine" post="Neurology. 2013 81 14 1191 1196 10.1212/WNL.0b013e3182a6cb72 23975872 215."/>
  <result pre="acid receptor activation; implications for the treatment of post-injury pain" exact="hypersensitivity" post="states Pain. 1991 44 3 293 299 10.1016/0304-3959(91)90100-C 1828878"/>
  <result pre="MF Yarnitsky D The development of cutaneous allodynia during a" exact="migraine" post="attack clinical evidence for the sequential recruitment of spinal"/>
  <result pre="the sequential recruitment of spinal and supraspinal nociceptive neurons in" exact="migraine" post="Brain. 2000 123 Pt 8 1703 1709 10.1093/brain/123.8.1703 10908199"/>
  <result pre="225. Selby G Lance JW Observations on 500 cases of" exact="migraine" post="and allied vascular headache J Neurol Neurosurg Psychiatry 1960"/>
  <result pre="J Neurochemistry of trigeminal activation in an animal model of" exact="migraine" post="Headache. 2006 46 Suppl 1 S39 S44 10.1111/j.1526-4610.2006.00489.x 16927963"/>
 </snippets>
</snippetsTree>
